The university can only enroll several hundred people in a clinical trial, given its timeframe, so it is picking volunteers who are at high risk of severe symptoms and infection.
The vaccine arrived in Oregon and other states on Monday marking the first step in a months-long drive to get people protected against COVID-19.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
Though cases are soaring, Oregon has yet to reach a critical shortage of intensive care beds in part because doctors have learned to treat patients early and now have more drugs.
The Oregon Medical Board has taken more than 200 actions against physicians this year but these are the first emergency suspensions.
Gov. Kate Brown, Oregon's two U.S. senators and four U.S. representatives have asked the U.S. Department of Health and Human Services to extend the health insurance enrollment period through Dec. 31.
The institution seeks volunteers for a promising vaccine developed by Oxford University in Britain in collaboration with AstraZeneca, a British pharmaceutical company.
After the nurses filed a federal complaint and complained to Unity's president, Legacy Health negotiators offered about 10 more dates for bargaining sessions.
Though the death rate from COVID-19 has dropped since the pandemic hit, the hospital system wants to be prepared if there is an overflow of deaths.